APVO
USDAptevo Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$0.440
Hoch
$0.468
Tief
$0.423
Volumen
0.00M
Unternehmensfundamentaldaten
Marktkapitalisierung
2.5M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
3.00M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immune-oncology
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel
Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SEATTLE, WASHINGTON / ACCESS Newswire / April 4, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel
Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
SEATTLE, WA / ACCESS Newswire / April 3, 2025 / Aptevo Therapeutics Inc. , a clinical-stage biotechnology company focused on developing novel immune-oncology
Ähnliche Aktien
RGR
Sturm Ruger & Company Inc.
NOW
ServiceNow Inc.
TPGXL
TPG Operating Group II L.P. 6.950% Fixed-Rate Junior Subordinated Notes due 2064
KVYO
Klaviyo Inc. Series A
ABEV
Ambev S.A. American Depositary Shares (Each representing 1 Common Share)
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.